Found: 10
Select item for more details and to access through your institution.
AZD9567 versus prednisolone in patients with active rheumatoid arthritis: A phase IIa, randomized, double‐blind, efficacy, and safety study.
- Published in:
- CTS: Clinical & Translational Science, 2023, v. 16, n. 12, p. 2494, doi. 10.1111/cts.13624
- By:
- Publication type:
- Article
A Randomized Trial of Dual-Acting Bronchodilator AZD8871 for Chronic Obstructive Pulmonary Disease.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2019, v. 199, n. 10, p. 1282, doi. 10.1164/rccm.201812-2345LE
- By:
- Publication type:
- Article
A Randomized Trial of Dual-Acting Bronchodilator AZD8871 for Chronic Obstructive Pulmonary Disease.
- Published in:
- 2019
- By:
- Publication type:
- letter
A Randomized Phase I Study of the Anti‐Interleukin‐33 Antibody Tozorakimab in Healthy Adults and Patients With Chronic Obstructive Pulmonary Disease.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 115, n. 3, p. 565, doi. 10.1002/cpt.3147
- By:
- Publication type:
- Article
Navafenterol (AZD8871) in healthy volunteers: safety, tolerability and pharmacokinetics of multiple ascending doses of this novel inhaled, long-acting, dual-pharmacology bronchodilator, in two phase I, randomised, single-blind, placebo-controlled studies.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Navafenterol (AZD8871) in patients with COPD: a randomized, double-blind, phase I study evaluating safety and pharmacodynamics of single doses of this novel, inhaled, long-acting, dual-pharmacology bronchodilator.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Characteristics of New Users of Aclidinium Bromide, Aclidinium/Formoterol, and Other COPD Medications in the United Kingdom, Denmark, and Germany.
- Published in:
- Clinical Drug Investigation, 2022, v. 42, n. 4, p. 319, doi. 10.1007/s40261-022-01120-2
- By:
- Publication type:
- Article
Risk Assessment of Acute Myocardial Infarction and Stroke Associated with Long-Acting Muscarinic Antagonists, Alone or in Combination, versus Long-Acting beta2-Agonists.
- Published in:
- International Journal of COPD, 2022, v. 17, p. 1715, doi. 10.2147/COPD.S363997
- By:
- Publication type:
- Article
A Cohort Study to Evaluate the Risk of Hospitalisation for Congestive Heart Failure Associated with the Use of Aclidinium and Other Chronic Obstructive Pulmonary Disease Medications in the UK Clinical Practice Research Datalink.
- Published in:
- International Journal of COPD, 2021, v. 16, p. 1461, doi. 10.2147/COPD.S301624
- By:
- Publication type:
- Article
A Phase 1, Randomized, Double‐Blind, Placebo‐Controlled, Single Ascending Dose Study to Evaluate the Pharmacokinetics, Immunogenicity, Safety, and Tolerability After Subcutaneous Administration of Tozorakimab in Healthy Chinese Participants.
- Published in:
- Clinical Pharmacology in Drug Development, 2024, v. 13, n. 6, p. 665, doi. 10.1002/cpdd.1391
- By:
- Publication type:
- Article